u/ZealotOfCannabis

Reddit r/stocks
· tracked since Apr 2026
Calls 4 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 4
Best Calls
TCNNF long +34.9%
MSOS long +0.9%
Worst Calls
CURLF long -8.8%
GTBIF long -4.1%
Most Mentioned
MSOS ×1
GTBIF ×1
TCNNF ×1
Recent Calls
CURLF long 1 month ago
TCNNF long 1 month ago
GTBIF long 1 month ago
Win Rate 50% Long 4 Short 0
Win Rate
7d 25%
30d 0%
90d
Average Return +5.7% Long Return +5.7% Short Return -
Average Return
7d -6.9%
30d -16.3%
90d
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
Opened
Entry
P&L
Thesis
Theme
Source
Long
Apr 22
$11.97
-8.8%
Curaleaf Holdings gains from rescheduling through tax relief and federal recognition. Enhanced earnings potential drives stock revaluation amid sector optimism. CURLF up over 20% on news, with room for growth if policy enacted. Rescheduling delays; industry oversupply pressures.
Curaleaf Holdings gains from rescheduling through tax relief and federal recognition. Enhanced earnings potential drives stock revaluation amid sector optimism. CURLF up over 20% on news, with room for growth if policy enacted. Rescheduling delays; industry oversupply pressures.
Consumer
Long
Apr 22
$8.55
-4.1%
Rescheduling enables tax deductions for Green Thumb Industries, lowering effective tax rate. Improved net income enhances stock attractiveness amid sector rally. GTBIF up over 20% on news, with further gains likely from policy shift. Company-specific operational issues; rescheduling may not materialize.
Rescheduling enables tax deductions for Green Thumb Industries, lowering effective tax rate. Improved net income enhances stock attractiveness amid sector rally. GTBIF up over 20% on news, with further gains likely from policy shift. Company-specific operational issues; rescheduling may not materialize.
Consumer
Long
Apr 22
$5.42
+0.9%
Cannabis rescheduling to Schedule III is expected, allowing business expense deductions and medical recognition. This improves profitability and legal standing for U.S. cannabis companies, driving ETF appreciation. MSOS rallied 25% on news and may continue upward as rescheduling finalizes. Rescheduling delay or failure; structural industry headwinds remain.
Cannabis rescheduling to Schedule III is expected, allowing business expense deductions and medical recognition. This improves profitability and legal standing for U.S. cannabis companies, driving ETF appreciation. MSOS rallied 25% on news and may continue upward as rescheduling finalizes. Rescheduling delay or failure; structural industry headwinds remain.
Healthcare
Long
Apr 22
$8.70
+34.9%
Trulieve Cannabis Corp. benefits from rescheduling via tax savings and medical legitimacy. Financial improvement fuels investor sentiment, amplifying price gains. TCNNF rose over 20% and may trend higher with policy implementation. Execution challenges; regulatory uncertainties persist.
Trulieve Cannabis Corp. benefits from rescheduling via tax savings and medical legitimacy. Financial improvement fuels investor sentiment, amplifying price gains. TCNNF rose over 20% and may trend higher with policy implementation. Execution challenges; regulatory uncertainties persist.
Consumer
Showing 4 of 4 picks ยท sorted by mentions